A multihormonal tumor of the pancreas producing neurotensin associated with the WDHA syndrome. Histology, histochemistry and origin.

Abstract

A pancreatic tumor associated with severe WDHA syndrome has been studied histologically and immunohistochemically. Light microscopy revealed that the growth pattern of the tumor varied greatly from zone to zone but with prevailing solid arrangement of the tumoral cells. The majority of the endocrine cells showed numerous eosinophilic, PTAH-positive, and argyrophilic secretory granules, that were ultrastructurally similar to those of normal and tumoral neurotensin-containing cells. A minority of the endocrine cells had secretory granules ultrastructurally different from the aforementioned ones, but these were not diagnostic on purely morphological grounds. Inside the tumor, immunohistochemistry demonstrated a majority of neurotensin-immunoreactive cells, sparse and small clusters of VIP-immunoreactive cells and few, dispersed pancreatic polypeptide-immunoreactive cells. Some structural and ultrastructural aspects of the tumoral stroma have also been reported. Ducts and solid masses of duct-like cells were also found, and small clusters and singly dispersed duct-like cells were seen invading the endocrine tissue and undergoing mitoses. Such features suggest that the tumor originated from precursors located in the medium-sized and small pancreatic ducts. Because of the multihormonal nature of the tumor, the role of neurotensin and VIP in producing the patient's symptoms is discussed and a synergistic action of the two hormones is suggested in causing the particularly severe WDHA syndrome.

• Authors: T Bani-Sacchi, G Bartolini, G Biliotti
• Journal: Histology and histopathology (Histol Histopathol) Vol. 1 Issue 2 Pg. 187-95 (Apr 1986) ISSN: 0213-3911 [Print] Spain
• PMID: 2856535 (Publication Type: Case Reports, Journal Article)

Chemical References

• Vasoactive Intestinal Peptide
• Neurotensin
• Pancreatic Polypeptide

Topics

• Adult
• Humans
• Immunohistochemistry
• Male
• Neurotensin (metabolism)
• Pancreatic Neoplasms (etiology, metabolism, ultrastructure)
• Pancreatic Polypeptide (metabolism)
• Paraneoplastic Endocrine Syndromes
• Vasoactive Intestinal Peptide (metabolism)
• Vipoma (etiology, metabolism, ultrastructure)